Trial intelligence / Profile preview

Effect of Carbamazepine on PF-07248144 Pharmacokinetics

NCT07198035Phase 1Completed

Sponsor
Pfizer
Start
Sep 2025
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of prifetrastat, sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Curve From Time Zero to Extrapolated Infinite Time and 1 more. Started Sep 2025; status: completed.

02

Drugs

prifetrastat

Beyond the preview

Go deeper on NCT07198035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07198035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call